ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Ralph E. Delius
Marc R. de Leval
Duncan J. Macrae
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goldman, A. P.
Right arrow Articles by Macrae, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goldman, A. P.
Right arrow Articles by Macrae, D. J.

Ann Thorac Surg 1996;62:750-755
© 1996 The Society of Thoracic Surgeons

Original Articles: Cardiovascular

Nitric Oxide Might Reduce the Need for Extracorporeal Support in Children With Critical Postoperative Pulmonary Hypertension

Allan P. Goldman, MRCP, Ralph E. Delius, MD, John E. Deanfield, FRCP, Marc R. de Leval, MD, Paul E. Sigston, FRCA, Duncan J. Macrae, FRCA

Cardiothoracic Unit, Great Ormond Street Hospital for Children, London, United Kingdom

Accepted for publication April 23, 1996.

Background. Postoperative pulmonary hypertension is a life-threatening, yet reversible complication of congenital heart operations. Although inhaled nitric oxide (iNO), a selective pulmonary vasodilator, has been shown extensively to improve short-term oxygenation and hemodynamic indices in these patients, its influence on patient outcome has not been evaluated. The purpose of this study was to assess retrospectively whether patients who fulfilled our criteria for extracorporeal life support (ECLS) for critical postoperative pulmonary hypertension still required ECLS after the administration of iNO therapy.

Methods. Since January 1992, 10 patients (age 3 days to 10 months) fulfilled the criteria at our institution for ECLS for postoperative pulmonary hypertension. Of these, 5 could not be separated from cardiopulmonary bypass because of pulmonary hypertension, and 5 had critical pulmonary hypertension (pulmonary arterial pressure approaching systemic arterial pressure) causing severe cardiopulmonary compromise.

Results. Six of the 10 ECLS candidates had a sustained response to iNO and survived to discharge from the hospital, without the need for rescue ECLS. Three patients still required ECLS after 30 minutes, 4 hours, and 8 hours of beginning iNO because of failing cardiac output, and 2 survived. The remaining patient died after 5 days of iNO therapy, but was no longer a candidate for ECLS because of sepsis and multiorgan system failure.

Conclusions. Children with critical pulmonary hypertension unresponsive to maximal conventional treatment may be managed successfully with iNO without the need for rescue ECLS. A trial of iNO should therefore be given before the use of ECLS in these patients.




This article has been cited by other articles:


Home page
 ESC Textbook of Cardiovascular MedicineHome page
J. E. Deanfield, R. Yates, F. J. Meijboom, and B. J.M. Mulder
CHAPTER 10 Congenital Heart Disease in Children and Adults
ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
W. M. Novick, N. Sandoval, V. V. Lazorhysynets, V. Castillo, A. Baskevitch, X. Mo, R. W. Reid, B. Marinovic, and T. G. Di Sessa
Flap Valve Double Patch Closure of Ventricular Septal Defects in Children With Increased Pulmonary Vascular Resistance
Ann. Thorac. Surg., January 1, 2005; 79(1): 21 - 28.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
P. Aylin, A. Bottle, B. Jarman, and P. Elliott
Paediatric cardiac surgical mortality in England after Bristol: descriptive analysis of hospital episode statistics 1991-2002
BMJ, October 9, 2004; 329(7470): 825.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
N. Nomura, M. Asano, T. Saito, S. Sasaki, H. Suzuki, T. Manabe, and A. Mishima
Cardiotrophin-1 is a prophylactic against the development of chronic hypoxic pulmonary hypertension in rats
Ann. Thorac. Surg., July 1, 2003; 76(1): 237 - 243.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
L. Lindberg, A. K. Olsson, P. Jogi, and C. Jonmarker
How common is severe pulmonary hypertension after pediatric cardiac surgery?
J. Thorac. Cardiovasc. Surg., June 1, 2002; 123(6): 1155 - 1163.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
R. W. Day, J. A. Hawkins, E. C. McGough, K. L. Crezee, and G. S. Orsmond
Randomized controlled study of inhaled nitric oxide after operation for congenital heart disease
Ann. Thorac. Surg., June 1, 2000; 69(6): 1907 - 1912.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
W. M. Novick, A. T. Gurbuz, D. C. Watson, V. V. Lazorishinets, A. N. Perepeka, I. Malcic, B. Marinovic, B. S. Alpert, and T. G. DiSessa
Double patch closure of ventricular septal defect with increased pulmonary vascular resistance
Ann. Thorac. Surg., November 1, 1998; 66(5): 1533 - 1538.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1996 by The Society of Thoracic Surgeons.